Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study

X. Montalban, G. Comi, P. O'Connor, S. M. Gold, A. de Vera, B. Eckert, L. Kappos

Research output: Contribution to journalArticleResearchpeer-review

55 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study'. Together they form a unique fingerprint.

Neuroscience